Patents by Inventor David Quartermain

David Quartermain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9265774
    Abstract: Pharmaceutical compositions containing a cocktail of inhibitors of central stress nuclei are provided. The pharmaceutical compositions are useful for the prevention and treatment of a variety of conditions in mammals including humans, including anxiety and mood disorders such as depression.
    Type: Grant
    Filed: April 13, 2012
    Date of Patent: February 23, 2016
    Assignee: New York University
    Inventors: Eric A. Stone, Lin Yan, David Quartermain, Yasmeen Sarfraz
  • Patent number: 9023788
    Abstract: Compounds and pharmaceutical compositions containing such compounds having formula I are provided: where R1, R2a, R2b, R3, R4, and R5 are as defined herein. The compounds and pharmaceutical compositions thereof are useful for the prevention and treatment of a variety of conditions in mammals including humans, including anxiety and mood disorders such as depression.
    Type: Grant
    Filed: April 19, 2011
    Date of Patent: May 5, 2015
    Assignee: New York University
    Inventors: Eric A. Stone, Yan Lin, David Quartermain, Yasmeen Sarfraz
  • Publication number: 20140107087
    Abstract: Pharmaceutical compositions containing a cocktail of inhibitors of central stress nuclei are provided. The pharmaceutical compositions are useful for the prevention and treatment of a variety of conditions in mammals including humans, including anxiety and mood disorders such as depression.
    Type: Application
    Filed: April 13, 2012
    Publication date: April 17, 2014
    Inventors: Eric A. Stone, Lin Yan, David Quartermain, Yasmeen Sarfraz
  • Publication number: 20120010125
    Abstract: Compounds and pharmaceutical compositions containing such compounds having formula I are provided: where R1, R2a, R2b, R3, R4, and R5 are as defined herein. The compounds and pharmaceutical compositions thereof are useful for the prevention and treatment of a variety of conditions in mammals including humans, including anxiety and mood disorders such as depression.
    Type: Application
    Filed: April 19, 2011
    Publication date: January 12, 2012
    Inventors: Eric A. Stone, Yan Lin, David Quartermain, Yasmeen Sarfraz